{"transactions":[{"id":719161,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719160,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-01-01","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719159,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":39604,"price":1.01,"value":40000.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock.  The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01."}],"balance_after":173050,"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719158,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":1,"value":40000.0,"ownership":{"direct":true},"balance_after":212654,"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":961428,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":68750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":68750},"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":961427,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":13750,"price":2,"value":27500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 55,000 shares of common stock on the net exercise of option to purchase 68,750 shares of common stock.  The issuer withheld 13,750 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.00."}],"balance_after":172654,"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":961426,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-17","kind":"exercise","planned":false,"acquired":true,"shares":68750,"price":0.4,"value":27500.0,"ownership":{"direct":true},"balance_after":186404,"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":1076666,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:36:44.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":120313,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":120313},"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076665,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:36:44.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":27659,"price":1.74,"value":48126.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 92,654 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":117654,"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076664,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:36:44.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120313,"price":0.4,"value":48125.2,"ownership":{"direct":true},"balance_after":145313,"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076662,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:26:56.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":120313,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":120313},"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1076661,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:26:56.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":27659,"price":1.74,"value":48126.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 90,606 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":117654,"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1076660,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:26:56.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120313,"price":0.4,"value":48125.2,"ownership":{"direct":true},"balance_after":145313,"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1450698,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:58:42.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0.33,"value":13200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-24-023228","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023228/rdgdoc.xml","form_type":"4"}},{"id":2290522,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:34:28.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-22-009789","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009789/rdgdoc.xml","form_type":"4"}},{"id":2290521,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:34:28.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019"}],"balance_after":36666,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":36666},"source":{"system":"sec-edgar","filing":"0001437749-22-009789","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009789/rdgdoc.xml","form_type":"4"}},{"id":3710136,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-03T16:29:51.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":68750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68750,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2015-12-31","underlying":"COMMON STOCK","underlying_shares":68750},"source":{"system":"sec-edgar","filing":"0001091596-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000109159619000001/primary_doc.xml","form_type":"4"}},{"id":3846476,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-13T19:53:18.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":120313,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120313,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-09","underlying":"COMMON STOCK","underlying_shares":120313},"source":{"system":"sec-edgar","filing":"0001605411-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000160541118000002/primary_doc.xml","form_type":"4"}},{"id":4493252,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2017-01-12T01:17:13.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Of these options, 15,000 vested immediately, and 25,000 vested on 1/1/17."}],"balance_after":40000,"derivative":{"exercise_price":1,"expiration_date":"2026-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001144204-17-001878","document":"v456634_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000114420417001878/v456634_4.xml","form_type":"4"}}]}